Galderma Group AG
SIX:GALD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Galderma Group AG
SIX:GALD
|
CH |
Intrinsic Value
The intrinsic value of Galderma Group AG (GALD) under the Base Case is 91.77 CHF per share. Compared with the current market price of 192.85 CHF, the stock appears Overvalued by 52% .
The intrinsic value is calculated using the DCF method. The model assumes Galderma's net margin rises from 12% last year to 25% by 2031, more than double its highest level in the last five years. Revenue grows about 19% a year over the next three years, versus 11% over the last three.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Galderma Group Does
Galderma Group AG is a skin-health company that focuses on treatments and products for the skin, face, and body. It sells prescription dermatology medicines, injectable aesthetic treatments, and over-the-counter skin care products. Its portfolio includes products used by dermatologists, medical professionals, and consumers who want help with conditions such as acne, rosacea, eczema, and age-related skin concerns.
- Headquarters
- Switzerland CH
- Employees
- 7 676
- IPO date
- Mar 22, 2024
Earnings Waterfall
Galderma Group AG
The intrinsic value for Galderma Group AG (GALD) under the Base Case is 91.77 CHF.
Compared with the current market price of 192.85 CHF, the stock appears Overvalued by 52% .